Big Pharma Report: September 26, 1998
Have PFun!
BigKNY3
_________________________________________
Big Pharma Review
- Big Pharma (+2.3%) gained for the third consecutive week outpacing the Dow (+1.7%) and trailing the NASTie (+5.5%). Four Pharmas reached all-time highs; LLY, SGP, ABT, and PNU.
-PFE (+9.8%) was this week's leader on relatively little news. GLX (-5.4%) was the lurker reflecting analysts' downgrades.
-In September, Big Pharma (+13.3%) is doubling the Dow (+6.5%). Every Big Pharma is up led by AMGN (+25.7%), PNU (+21.3%), and LLY(+19.5%). PFE is closing strong up 14.7%.
-In the third quarter, Big Pharma is up 3.4% as compared to a 10.3% decline for the Dow. LLY (+18.6%) is the quarterly leader. PFE must increase 2.0% in the next 3 trading days in order to keep its streak in tact of 17 consecutive quarter to quarter gains. PFE is now only 12.4% off its all-time high set on 4/21/98.
-YTD, Big Pharma (+31.1%) continues to be the hot sector in a flat market (+1.5%). In the YTD race, WLA paced by an amazing Lipitor 41.4% market share is still #1 (+84.2%), followed by Claritin (SGP) (+63.0%), AHP (+49.3%) and PFE (+43.1%). LLY (+12.8%) has pulled ahead of SBH (+12.2%) and BMY (+6.3%).
_________________________________________________________
News You Can Use
-Viagra Specification Highlights
- Rxs for 9/11/98 reflected only a 4 day week due to the Labor Day holiday
-Adjusting for the holiday, New Rxs were flat (-0.6%) while Refill Rxs increased 5.8%. Total Rxs would have gained 2.8%
-Refills account for 55% of total specification...the highest % ever and the 24th consecutive weekly increase in this ratio.
-4.7 million Rxs have been written in only 24 weeks
..............Week ..........
.................9/11..............YTD..........Market
.................(000)..........Millions......Share
New Rxs ....67.9.......... 3.278........98.1%
Refill Rxs....81.3...........1.376........95.5%
Total Rxs.. 149.2..........4.654........97.3%
PFE Antibiotic Seen Reducing Heart Disease in Rabbit Study
news.com
PFE Sets $5 Billion Stock Buyback
cbs.marketwatch.com
SGP to Split 2-1
aol://4344:2783.B230908F.29427749.591026176
News From the Bear Stearns Health Conference (Go to the Drug Stock Column)
labpuppy.com
Viagra Success Cost Jobs in Navan
irish-times.com
HKS/Hemandt Shah on Lipitor:
"After a very rapid market penetration immediately after its launch during early 1997, Lipitor has continued to gain additional market share in a relatively crowded market for the treatment of high cholesterol. This incredible market share gain (41.4%) is a classic example of how two drug companies, PFE and WLA, carried out an extremely well-planned launch and despite strong counter measures by some of the largest and most dominant drug companies in the cardiovascular market, achieved unprecedented market share within months of its launch."
PFE Comparative Charts
This Weeks' PFE Price Action versus the Dow. Note the similarity of the trends! Amazing!!!
quicken.com
PFE versus the Dow since the NDA submission for Viagra.
quicken.com
Analysts' Roll-Call
- Broker Ratings Summary quicken.com
-Norby Broker Reports
nordby.com
Market Environment Links
-Briefing.com Market Updates
briefing.com
-Briefing.com Market Environment
briefing.com
-The Federal Reserve Beige Book
bog.frb.fed.us
Investment Advice
8 easy ways to lose your shirt in stocks
usatoday.com
IBD: 26 Weeks to Investing
ibd.infostreet.com
PFE News Links
Yahoo Link quote.yahoo.com
Motley Fool Link quote.fool.com
ED News Links
Yahoo Link quote.yahoo.com
Motley Fool Link quote.fool.com
Yahoo Viagra Link headlines.yahoo.com |
